Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists. - Wikidata - awgldk - TriplyDB

Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.

Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.

http://www.wikidata.org/entity/Q33583171

about

What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders?PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β.Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis.Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain.Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.

P2860

Q28083512-93DC6681-A430-4E50-8E74-393D33CE8167 Q36602023-97F4B9C4-5095-4A99-81A8-25B18F51D7DD Q38924615-6EBF8A4B-B848-4427-A5E4-7EF9A3C64F27 Q38939217-D79E7595-13C7-4FF5-89D1-4FF6BA218993 Q39370168-229D3555-CBA7-498A-A256-658F55293E78 Q39414464-9CA21B95-1F6A-4270-9411-2A91F1989D9A

P2860

Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.

http://www.wikidata.org/entity/Q33583171

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Quantitative phosphoproteomics ...... us nonhallucinogenic agonists.

@ast

Quantitative phosphoproteomics ...... us nonhallucinogenic agonists.

@en

Quantitative phosphoproteomics ...... us nonhallucinogenic agonists.

@nl

type

label

Quantitative phosphoproteomics ...... us nonhallucinogenic agonists.

@ast

Quantitative phosphoproteomics ...... us nonhallucinogenic agonists.

@en

Quantitative phosphoproteomics ...... us nonhallucinogenic agonists.

@nl

prefLabel

Quantitative phosphoproteomics ...... us nonhallucinogenic agonists.

@ast

Quantitative phosphoproteomics ...... us nonhallucinogenic agonists.

@en

Quantitative phosphoproteomics ...... us nonhallucinogenic agonists.

@nl

P1433

Q33583171-429D1892-1384-492C-B416-1406E4797C11

P1476

Q33583171-10B30FD1-10AA-4AE0-B6CA-45686C2C30C0

P2093

Q33583171-48E740A8-A2FA-4EA1-9844-DDF5C015A923

Q33583171-7BCB418B-310D-4D8D-BD1F-02AA1624658A

Q33583171-8924F0C3-56C0-4C0C-9C85-2C85C29A266A

Q33583171-96294883-CB05-4E3E-B3BC-F7E36F6D6070

Q33583171-CD9D1451-8709-4E99-9D11-A5FCBAB4A658

Q33583171-F6EE81CB-E057-403B-9FA7-3585EEAB44A3

P2860

Q33583171-0833891D-69C2-4EA0-9199-CFFE04540C25

Q33583171-09295BA6-EC9C-491A-885B-31916EE20680

Q33583171-0E9AD419-E52F-417E-849B-2AC7ADC29CC3

Q33583171-119E93C2-A0B2-418B-9F32-9D2CEE2C2C56

Q33583171-1470A704-1E94-4594-AE9B-F7E3B0A05983

Q33583171-19C04C34-5BCA-4F80-A369-793D6CF99854

Q33583171-1E4D9C0D-3252-4AA9-8826-3D8CA1D84B17

Q33583171-29449988-B5EF-459B-9F74-6B3BB1A4CF8E

Q33583171-3267D173-AD8E-4367-B0D0-B3434212E3F6

Q33583171-36206478-5805-4973-89B9-FD0AAA674EA5

P304

Q33583171-EAEEA22C-EED3-47AF-9CD5-008359B874EE

P31

Q33583171-37F2799C-AD62-48B9-82DE-5780267EBD84

P356

Q33583171-94F13BCD-B858-42D6-ACBD-ED5FF2CC9A63

P433

Q33583171-F41BFE1F-A942-435C-8D89-60019654A5EB

P478

Q33583171-B8D87C29-A758-4406-A865-CE64A9D77EEC

P50

Q33583171-2B68DCFD-AA65-43B9-9F5D-3C929B5BDE05

Q33583171-7F95A703-3BF5-427F-AFBD-547DDAA56A45

Q33583171-8160CC57-D5D4-4FE5-8AF1-FC7A6CAFD691

P577

Q33583171-B54341FD-7797-43D4-B1CF-BDE3BBC91AE3

P5875

Q33583171-AAD277FE-44BE-46AC-980B-6F1033EAE888

P698

Q33583171-48430BFB-1CEB-4C84-A548-78FCE34BE99F

P921

Q33583171-2966abf5-641e-44ed-aba8-08ad0234a9f9

Q33583171-6BCF348D-066F-46DB-B5B4-1EBB817CE3F9

P932

Q33583171-204AE2CA-C72F-4DCB-A60D-27AC6B85D448

P356

MCP.M113.036558

P1433

Molecular & Cellular Proteomics

P1476

Quantitative phosphoproteomics ...... us nonhallucinogenic agonists.

@en

P2093

Carine Becamel

http://www.w3.org/2001/XMLSchema#string

Clotilde Mannoury la Cour

http://www.w3.org/2001/XMLSchema#string

Laurent Prézeau

http://www.w3.org/2001/XMLSchema#string

Mark J Millan

http://www.w3.org/2001/XMLSchema#string

Philippe Marin

http://www.w3.org/2001/XMLSchema#string

Samah Karaki

http://www.w3.org/2001/XMLSchema#string

P2860

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling

Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function

Phospho.ELM: a database of phosphorylation sites--update 2011

Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo

Identification of a serotonin/glutamate receptor complex implicated in psychosis

Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior

P304

1273-1285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M113.036558

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Franck Vandermoere

P577

2014-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260874531

http://www.w3.org/2001/XMLSchema#string

P698

24637012

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

4014284

http://www.w3.org/2001/XMLSchema#string